<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 1.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 09/30/2019-->
<!--Copyright (c) 2019 NTDAS Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://ipharminc.com/role/DocumentAndEntityInformation" xlink:href="ipix-20190630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/ConsolidatedBalanceSheets" xlink:href="ipix-20190630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ipix-20190630.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/ConsolidatedStatementsOfOperations" xlink:href="ipix-20190630.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="ipix-20190630.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ipix-20190630.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/BasisOfPresentationAndNatureOfOperations" xlink:href="ipix-20190630.xsd#BasisOfPresentationAndNatureOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/GoingConcernAndLiquidity" xlink:href="ipix-20190630.xsd#GoingConcernAndLiquidity" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:href="ipix-20190630.xsd#SignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/PatentsNet" xlink:href="ipix-20190630.xsd#PatentsNet" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/PropertyPlantAndEquipmentNet" xlink:href="ipix-20190630.xsd#PropertyPlantAndEquipmentNet" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/AccruedExpensesRelatedPartiesAndOther" xlink:href="ipix-20190630.xsd#AccruedExpensesRelatedPartiesAndOther" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/AccruedSalariesAndPayrollTaxesRelatedPartiesAndOther" xlink:href="ipix-20190630.xsd#AccruedSalariesAndPayrollTaxesRelatedPartiesAndOther" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/CommitmentsAndContingencies" xlink:href="ipix-20190630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/RelatedPartyTransactions" xlink:href="ipix-20190630.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/ConvertibleNotePayableRelatedParty" xlink:href="ipix-20190630.xsd#ConvertibleNotePayableRelatedParty" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/WeightedAverageSharesOutstanding" xlink:href="ipix-20190630.xsd#WeightedAverageSharesOutstanding" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstanding" xlink:href="ipix-20190630.xsd#EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstanding" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityTransactions" xlink:href="ipix-20190630.xsd#EquityTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SeriesB5ConvertiblePreferredStock" xlink:href="ipix-20190630.xsd#SeriesB5ConvertiblePreferredStock" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/FairValueMeasurement" xlink:href="ipix-20190630.xsd#FairValueMeasurement" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/IncomeTaxes" xlink:href="ipix-20190630.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SubsequentEvents" xlink:href="ipix-20190630.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:href="ipix-20190630.xsd#SignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:href="ipix-20190630.xsd#SignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/PatentsNetTables" xlink:href="ipix-20190630.xsd#PatentsNetTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/PropertyPlantAndEquipmentNetTables" xlink:href="ipix-20190630.xsd#PropertyPlantAndEquipmentNetTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/AccruedExpensesRelatedPartiesAndOtherTables" xlink:href="ipix-20190630.xsd#AccruedExpensesRelatedPartiesAndOtherTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/AccruedSalariesAndPayrollTaxesRelatedPartiesAndOtherTables" xlink:href="ipix-20190630.xsd#AccruedSalariesAndPayrollTaxesRelatedPartiesAndOtherTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/CommitmentsAndContingenciesTables" xlink:href="ipix-20190630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/WeightedAverageSharesOutstandingTables" xlink:href="ipix-20190630.xsd#WeightedAverageSharesOutstandingTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingTables" xlink:href="ipix-20190630.xsd#EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SeriesB5ConvertiblePreferredStockTables" xlink:href="ipix-20190630.xsd#SeriesB5ConvertiblePreferredStockTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/FairValueMeasurementTables" xlink:href="ipix-20190630.xsd#FairValueMeasurementTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/IncomeTaxesTables" xlink:href="ipix-20190630.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/BasisOfPresentationAndNatureOfOperationsDetailsNarrative" xlink:href="ipix-20190630.xsd#BasisOfPresentationAndNatureOfOperationsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/GoingConcernAndLiquidityDetailsNarrative" xlink:href="ipix-20190630.xsd#GoingConcernAndLiquidityDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:href="ipix-20190630.xsd#SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails1" xlink:href="ipix-20190630.xsd#SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:href="ipix-20190630.xsd#SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/PatentsNetDetails" xlink:href="ipix-20190630.xsd#PatentsNetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/PatentsNetDetailsNarrative" xlink:href="ipix-20190630.xsd#PatentsNetDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/PropertyPlantAndEquipmentNetDetails" xlink:href="ipix-20190630.xsd#PropertyPlantAndEquipmentNetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/PropertyPlantAndEquipmentNetDetailsNarrative" xlink:href="ipix-20190630.xsd#PropertyPlantAndEquipmentNetDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/AccruedExpensesRelatedPartiesAndOtherDetails" xlink:href="ipix-20190630.xsd#AccruedExpensesRelatedPartiesAndOtherDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/AccruedSalariesAndPayrollTaxesRelatedPartiesAndOtherDetails" xlink:href="ipix-20190630.xsd#AccruedSalariesAndPayrollTaxesRelatedPartiesAndOtherDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/CommitmentsAndContingenciesDetails" xlink:href="ipix-20190630.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="ipix-20190630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ipix-20190630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/ConvertibleNotePayableRelatedPartyDetailsNarrative" xlink:href="ipix-20190630.xsd#ConvertibleNotePayableRelatedPartyDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/WeightedAverageSharesOutstandingDetails" xlink:href="ipix-20190630.xsd#WeightedAverageSharesOutstandingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails" xlink:href="ipix-20190630.xsd#EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails1" xlink:href="ipix-20190630.xsd#EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails2" xlink:href="ipix-20190630.xsd#EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails3" xlink:href="ipix-20190630.xsd#EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails4" xlink:href="ipix-20190630.xsd#EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails4" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails5" xlink:href="ipix-20190630.xsd#EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails5" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails6" xlink:href="ipix-20190630.xsd#EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails6" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetailsNarrative" xlink:href="ipix-20190630.xsd#EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/EquityTransactionsDetailsNarrative" xlink:href="ipix-20190630.xsd#EquityTransactionsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SeriesB5ConvertiblePreferredStockDetails" xlink:href="ipix-20190630.xsd#SeriesB5ConvertiblePreferredStockDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SeriesB5ConvertiblePreferredStockDetailsNarrative" xlink:href="ipix-20190630.xsd#SeriesB5ConvertiblePreferredStockDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/FairValueMeasurementDetails" xlink:href="ipix-20190630.xsd#FairValueMeasurementDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/FairValueMeasurementDetailsNarrative" xlink:href="ipix-20190630.xsd#FairValueMeasurementDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/IncomeTaxesDetails" xlink:href="ipix-20190630.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/IncomeTaxesDetails1" xlink:href="ipix-20190630.xsd#IncomeTaxesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/IncomeTaxesDetailsNarrative" xlink:href="ipix-20190630.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://ipharminc.com/role/SubsequentEventsDetailsNarrative" xlink:href="ipix-20190630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/ConsolidatedBalanceSheets" xlink:title="0000002 - Statement - CONSOLIDATED BALANCE SHEETS" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/ConsolidatedStatementsOfOperations" xlink:title="0000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:title="0000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/BasisOfPresentationAndNatureOfOperations" xlink:title="0000007 - Disclosure - Basis of Presentation and Nature of Operations" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/GoingConcernAndLiquidity" xlink:title="0000008 - Disclosure - Going Concern and Liquidity" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncements" xlink:title="0000009 - Disclosure - Significant Accounting Policies and Recent Accounting Pronouncements" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/PatentsNet" xlink:title="000010 - Disclosure - Patents, net" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/PropertyPlantAndEquipmentNet" xlink:title="000011 - Disclosure - Property, plant and equipment, net" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/AccruedExpensesRelatedPartiesAndOther" xlink:title="000012 - Disclosure - Accrued Expenses - Related Parties and Other" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/AccruedSalariesAndPayrollTaxesRelatedPartiesAndOther" xlink:title="000013 - Disclosure - Accrued Salaries and Payroll Taxes - Related Parties And Other" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/CommitmentsAndContingencies" xlink:title="000014 - Disclosure - Commitments and Contingencies" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/RelatedPartyTransactions" xlink:title="000015 - Disclosure - Related Party Transactions" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/ConvertibleNotePayableRelatedParty" xlink:title="000016 - Disclosure - Convertible Note Payable - Related Party" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/WeightedAverageSharesOutstanding" xlink:title="000017 - Disclosure - Weighted Average Shares Outstanding" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstanding" xlink:title="000018 - Disclosure - Equity Incentive Plans, Stock-Based Compensation, Exercise of Options and Warrants Outstanding" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityTransactions" xlink:title="000019 - Disclosure - Equity Transactions" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SeriesB5ConvertiblePreferredStock" xlink:title="000020 - Disclosure - Series B 5 convertible preferred stock" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/FairValueMeasurement" xlink:title="000021 - Disclosure - Fair Value Measurement" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/IncomeTaxes" xlink:title="000022 - Disclosure - Income Taxes" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SubsequentEvents" xlink:title="000023 - Disclosure - Subsequent Events" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" xlink:title="000024 - Disclosure - Significant Accounting Policies and Recent Accounting Pronouncements (Policies)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsTables" xlink:title="000025 - Disclosure - Significant Accounting Policies and Recent Accounting Pronouncements (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/PatentsNetTables" xlink:title="000026 - Disclosure - Patents, net (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/PropertyPlantAndEquipmentNetTables" xlink:title="000027 - Disclosure - Property, plant and equipment, net (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/AccruedExpensesRelatedPartiesAndOtherTables" xlink:title="000028 - Disclosure - Accrued Expenses Related Parties and Other (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/AccruedSalariesAndPayrollTaxesRelatedPartiesAndOtherTables" xlink:title="000029 - Disclosure - Accrued Salaries and Payroll Taxes Related Parties And Other (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/CommitmentsAndContingenciesTables" xlink:title="000030 - Disclosure - Commitments and Contingencies (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/WeightedAverageSharesOutstandingTables" xlink:title="000031 - Disclosure - Weighted Average Shares Outstanding (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingTables" xlink:title="000032 - Disclosure - Equity Incentive Plans StockBased Compensation Exercise of Options and Warrants Outstanding (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SeriesB5ConvertiblePreferredStockTables" xlink:title="000033 - Disclosure - Series B 5 convertible preferred stock (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/FairValueMeasurementTables" xlink:title="000034 - Disclosure - Fair Value Measurement (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/IncomeTaxesTables" xlink:title="000035 - Disclosure - Income Taxes (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/BasisOfPresentationAndNatureOfOperationsDetailsNarrative" xlink:title="000036 - Disclosure - Basis of Presentation and Nature of Operations (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/GoingConcernAndLiquidityDetailsNarrative" xlink:title="000037 - Disclosure - Going Concern and Liquidity (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails" xlink:title="000038 - Disclosure - Significant Accounting Policies and Recent Accounting Pronouncements (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetails1" xlink:title="000039 - Disclosure - Significant Accounting Policies and Recent Accounting Pronouncements (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SignificantAccountingPoliciesAndRecentAccountingPronouncementsDetailsNarrative" xlink:title="000040 - Disclosure - Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/PatentsNetDetails" xlink:title="000041 - Disclosure - Patents, net (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/PatentsNetDetailsNarrative" xlink:title="000042 - Disclosure - Patents, net (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/PropertyPlantAndEquipmentNetDetails" xlink:title="000043 - Disclosure - Property, plant and equipment, net (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/PropertyPlantAndEquipmentNetDetailsNarrative" xlink:title="000044 - Disclosure - Property, plant and equipment, net (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/AccruedExpensesRelatedPartiesAndOtherDetails" xlink:title="000045 - Disclosure - Accrued Expenses - Related Parties and Other (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/AccruedSalariesAndPayrollTaxesRelatedPartiesAndOtherDetails" xlink:title="000046 - Disclosure - Accrued Salaries and Payroll Taxes - Related Parties And Other (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/CommitmentsAndContingenciesDetails" xlink:title="000047 - Disclosure - Commitments and Contingencies (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="000048 - Disclosure - Commitments and Contingencies (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="000049 - Disclosure - Related Party Transactions (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/ConvertibleNotePayableRelatedPartyDetailsNarrative" xlink:title="000050 - Disclosure - Convertible Note Payable Related Party (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/WeightedAverageSharesOutstandingDetails" xlink:title="000051 - Disclosure - Weighted Average Shares Outstanding (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails" xlink:title="000052 - Disclosure - Equity Incentive Plans, Stock-Based Compensation, Exercise of Options and Warrants Outstanding (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails1" xlink:title="000053 - Disclosure - Equity Incentive Plans StockBased Compensation Exercise of Options and Warrants Outstanding (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails2" xlink:title="000054 - Disclosure - Equity Incentive Plans StockBased Compensation Exercise of Options and Warrants Outstanding (Details 2)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails3" xlink:title="000055 - Disclosure - Equity Incentive Plans StockBased Compensation Exercise of Options and Warrants Outstanding (Details 3)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails4" xlink:title="000056 - Disclosure - Equity Incentive Plans, Stock-Based Compensation, Exercise of Options and Warrants Outstanding (Details 4)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails5" xlink:title="000057 - Disclosure - Equity Incentive Plans StockBased Compensation Exercise of Options and Warrants Outstanding (Details 5)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityIncentivePlansStockBasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetails6" xlink:title="000058 - Disclosure - Equity Incentive Plans, Stock-Based Compensation, Exercise of Options and Warrants Outstanding (Details 6)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityIncentivePlansStockbasedCompensationExerciseOfOptionsAndWarrantsOutstandingDetailsNarrative" xlink:title="000059 - Disclosure - Equity Incentive Plans StockBased Compensation Exercise of Options and Warrants Outstanding (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/EquityTransactionsDetailsNarrative" xlink:title="000060 - Disclosure - Equity Transactions (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SeriesB5ConvertiblePreferredStockDetails" xlink:title="000061 - Disclosure - Series B 5 convertible preferred stock (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SeriesB5ConvertiblePreferredStockDetailsNarrative" xlink:title="000062 - Disclosure - Series B 5 convertible preferred stock (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/FairValueMeasurementDetails" xlink:title="000063 - Disclosure - Fair Value Measurement (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/FairValueMeasurementDetailsNarrative" xlink:title="000064 - Disclosure - Fair Value Measurement (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/IncomeTaxesDetails" xlink:title="000065 - Disclosure - Income Taxes (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/IncomeTaxesDetails1" xlink:title="000066 - Disclosure - Income Taxes (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/IncomeTaxesDetailsNarrative" xlink:title="000067 - Disclosure - Income Taxes (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://ipharminc.com/role/SubsequentEventsDetailsNarrative" xlink:title="000068 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>


